SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites.
作者信息
Saffo Saad, Taddei Tamar
机构信息
Department of Internal Medicine Yale University School of Medicine New Haven CT.
Section of Digestive Diseases Yale University School of Medicine New Haven CT.
出版信息
Clin Liver Dis (Hoboken). 2018 Jul 26;11(6):141-144. doi: 10.1002/cld.714. eCollection 2018 Jun.
Abstract
摘要
相似文献
1
SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites.
Clin Liver Dis (Hoboken). 2018 Jul 26;11(6):141-144. doi: 10.1002/cld.714. eCollection 2018 Jun.
2
Turning Foes to Friends: Knocking Down Diabetes Associated SGLT2 Transporters and Sustaining Life.
Curr Diabetes Rev. 2020;16(7):716-732. doi: 10.2174/1573399816666200117155016.
3
SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus.
J Pharm Pharmacol. 2013 Mar;65(3):317-27. doi: 10.1111/j.2042-7158.2012.01574.x. Epub 2012 Aug 9.
4
[Relative frequency of urinary tract infections in patients affected by diabetes mellitus type 2 treated with metformin and SGLT2 inhibitor. ].
Orv Hetil. 2020 Mar;161(13):491-501. doi: 10.1556/650.2020.31690.
5
Update on SGLT2 Inhibitors-New Data Released at the American Diabetes Association.
Crit Pathw Cardiol. 2017 Sep;16(3):93-95. doi: 10.1097/HPC.0000000000000125.
6
Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus.
Curr Drug Saf. 2019;14(2):87-93. doi: 10.2174/1574886314666190206164647.
7
Sodium glucose CoTransporter 2 (SGLT2) inhibitors: Current status and future perspective.
Eur J Pharm Sci. 2016 Oct 10;93:244-52. doi: 10.1016/j.ejps.2016.08.025. Epub 2016 Aug 12.
8
SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
Postgrad Med. 2014 Jan;126(1):111-7. doi: 10.3810/pgm.2014.01.2731.
9
Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction.
Curr Top Med Chem. 2019;19(20):1818-1849. doi: 10.2174/1568026619666190828161409.
10
Effects of Sodium-glucose Cotransporter 2 Inhibitor Monotherapy on Weight Changes in Patients With Type 2 Diabetes Mellitus: a Bayesian Network Meta-analysis.
Clin Ther. 2019 Feb;41(2):322-334.e11. doi: 10.1016/j.clinthera.2019.01.001. Epub 2019 Jan 30.
引用本文的文献
1
Complete Resolution of Refractory Ascites and Pleural Effusion with Sustained Improvement in Urinary Sodium Excretion in a Cirrhotic Patient Treated with Empagliflozin.
J Clin Transl Hepatol. 2025 Aug 28;13(8):701-704. doi: 10.14218/JCTH.2025.00172. Epub 2025 Jun 19.
2
Therapeutic Potential of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Liver Disease: Focus on Cirrhosis.
Cureus. 2025 May 25;17(5):e84768. doi: 10.7759/cureus.84768. eCollection 2025 May.
3
Dapagliflozin and metabolic dysfunction-associated steatohepatitis.
BMJ. 2025 Jun 4;389:r1101. doi: 10.1136/bmj.r1101.
4
Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study.
Dig Dis Sci. 2025 Feb;70(2):835-842. doi: 10.1007/s10620-024-08667-4. Epub 2024 Oct 9.
5
Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons.
Gut Liver. 2024 Nov 15;18(6):934-948. doi: 10.5009/gnl240038. Epub 2024 Aug 29.
6
Clinical Presentation, Pathological Spectrum, and Outcomes of Alcoholic Cirrhosis-Related Immunoglobulin A Nephropathy.
Kidney Int Rep. 2024 Feb 16;9(5):1369-1378. doi: 10.1016/j.ekir.2024.02.1397. eCollection 2024 May.
7
From liver to hormones: The endocrine consequences of cirrhosis.
World J Gastroenterol. 2024 Mar 7;30(9):1073-1095. doi: 10.3748/wjg.v30.i9.1073.
8
Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis.
BMC Gastroenterol. 2023 Dec 19;23(1):450. doi: 10.1186/s12876-023-03085-8.
9
Innovative approaches to the management of ascites in cirrhosis.
JHEP Rep. 2023 Apr 5;5(7):100749. doi: 10.1016/j.jhepr.2023.100749. eCollection 2023 Jul.
10
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
Medicina (Kaunas). 2023 Apr 10;59(4):742. doi: 10.3390/medicina59040742.
本文引用的文献
1
Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.
Circulation. 2016 Sep 6;134(10):752-72. doi: 10.1161/CIRCULATIONAHA.116.021887. Epub 2016 Jul 28.
2
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.
Eur Heart J. 2016 May 14;37(19):1526-34. doi: 10.1093/eurheartj/ehv728. Epub 2016 Jan 26.
3
The treatment of diabetes mellitus of patients with chronic liver disease.
Ann Hepatol. 2015 Nov-Dec;14(6):780-8. doi: 10.5604/16652681.1171746.
4
The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.
Annu Rev Med. 2015;66:255-70. doi: 10.1146/annurev-med-051013-110046. Epub 2014 Oct 17.
5
Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events.
Drug Saf. 2014 Oct;37(10):815-29. doi: 10.1007/s40264-014-0213-4.
6
Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.
Hepatology. 2014 Dec;60(6):2008-16. doi: 10.1002/hep.27199. Epub 2014 Jul 31.
7
The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells.
Front Endocrinol (Lausanne). 2014 Feb 4;5:10. doi: 10.3389/fendo.2014.00010. eCollection 2014.
8
The changing role of beta-blocker therapy in patients with cirrhosis.
J Hepatol. 2014 Mar;60(3):643-53. doi: 10.1016/j.jhep.2013.09.016. Epub 2013 Sep 26.
9
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes.
Diabetes Obes Metab. 2013 Jul;15(7):613-21. doi: 10.1111/dom.12073. Epub 2013 Feb 17.
10
Influence of hepatic impairment on the pharmacokinetics and safety profile of dapagliflozin: an open-label, parallel-group, single-dose study.
Clin Ther. 2011 Nov;33(11):1798-808. doi: 10.1016/j.clinthera.2011.09.011. Epub 2011 Oct 26.
Zotero 插件